BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
247 hedge funds and large institutions have $8B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 79 increasing their positions, 86 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
247
Holders Change
+25
Holders Change %
+11.26%
% of All Funds
4.34%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.25%
New
55
Increased
79
Reduced
86
Closed
29
Calls
$96.7M
Puts
$76.2M
Net Calls
+$20.5M
Net Calls Change
+$7.46M
Top Buyers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$72.3M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
$416M |
| 3 |
Wells Fargo
San Francisco,
California
|
$247M |
| 4 |
Holocene Advisors
New York
|
$41.5M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
$37.2M |
